Compare Multistrada Arah Sarana Tbk. (MASA) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Multistrada Arah Sarana Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Multistrada Arah Sarana Tbk. trades at Rp6,200 (market cap 56.93T), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Multistrada Arah Sarana Tbk. is far larger — about 545.3× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| MASA | SCPI | |
|---|---|---|
Market Cap | 56.93T | 104.4B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Multistrada Arah Sarana Tbk.
Multistrada Arah Sarana, PT (the company) was established under its original name of PT Oroban Perkasa on Jun 20th 1988. The company starts commercial operation in 1995. The articles of association have been amended several times, most recently on January 31, 2005, concerning public offering.
Read more on MASA →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
